Chlamydia pneumoniae and osteoporosis-associated bone loss: a new risk factor? (Q37847655)

24 August 2017

title

Chlamydia pneumoniae and osteoporosis-associated bone loss: a new risk factor? (English)

1 reference

24 August 2017

0 references

0 references

Chlamydia pneumoniae

1 reference

M Di Pietro

1

1 reference

24 August 2017

G Schiavoni

2

1 reference

24 August 2017

V Sessa

3

1 reference

24 August 2017

F Pallotta

4

1 reference

24 August 2017

G Costanzo

5

1 reference

24 August 2017

R Sessa

6

1 reference

24 August 2017

language of work or name

English

0 references

publication date

16 November 2012

1 reference

Osteoporosis International

24 August 2017

published in

1 reference

24 August 2017

volume

24

1 reference

24 August 2017

issue

5

1 reference

24 August 2017

page(s)

1677-1682

1 reference

https://scigraph.springernature.com/pub.10.1007/s00198-012-2217-1

24 August 2017

exact match

0 references

cites work

Osteoporosis: now and the future

1 reference

https://api.crossref.org/works/10.1007%2FS00198-012-2217-1

Current and future treatment options in osteoporosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00198-012-2217-1

Staphylococcus aureus protein A binds to osteoblasts and triggers signals that weaken bone in osteomyelitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00198-012-2217-1

Proinflammatory response of human osteoblastic cell lines and osteoblast-monocyte interaction upon infection with Brucella spp.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00198-012-2217-1

Cytokines that promote periodontal tissue destruction

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00198-012-2217-1

Osteoblast responses to bacterial pathogens: a previously unappreciated role for bone-forming cells in host defense and disease progression

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00198-012-2217-1

Chlamydia pneumoniae infection results in generalized bone loss in mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00198-012-2217-1

Induction of proinflammatory cytokines in human osteoblastic cells by Chlamydia pneumoniae.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00198-012-2217-1

Divergent modulation of Chlamydia pneumoniae infection cycle in human monocytic and endothelial cells by iron, tryptophan availability and interferon gamma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00198-012-2217-1

Chlamydia pneumoniae and atherosclerosis: current state and future prospectives

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00198-012-2217-1

Chlamydia-induced ReA: immune imbalances and persistent pathogens.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00198-012-2217-1

Persistent Chlamydiae and chronic arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00198-012-2217-1

Acellular components of Chlamydia pneumoniae stimulate cytokine production in human blood mononuclear cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00198-012-2217-1

Tumor necrosis factor-alpha mediates orthopedic implant osteolysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00198-012-2217-1

Measurement of Chlamydia pneumoniae bacterial load in peripheral blood mononuclear cells may be helpful to assess the state of chlamydial infection in patients with carotid atherosclerotic disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00198-012-2217-1

Phagocytes transmit Chlamydia pneumoniae from the lungs to the vasculature.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00198-012-2217-1

Chlamydia pneumoniae present in the human synovium are viable and metabolically active.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00198-012-2217-1

Chlamydiae as etiologic agents in chronic undifferentiated spondylarthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00198-012-2217-1

Bone development: overview of bone cells and signaling.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00198-012-2217-1

Aggregatibacter actinomycetemcomitans–Induced Bone Loss and Antibody Response in Three Rat Strains

21 January 2018

1 reference

12 December 2020

Assessment of fracture risk and its application to screening for postmenopausal osteoporosis. Report of a WHO Study Group

1 reference

12 December 2020

Analysis of gene expression in penicillin G induced persistence of Chlamydia pneumoniae

1 reference

12 December 2020

Pathogens and atherosclerosis: update on the potential contribution of multiple infectious organisms to the pathogenesis of atherosclerosis

1 reference

12 December 2020

Cytokine response of lymphocytes persistently infected with Chlamydia pneumoniae

1 reference

12 December 2020

10.1007/S00198-012-2217-1

Identifiers

DOI

1 reference

24 August 2017

1 reference